Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group (Q45275926)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group
scientific article

    Statements

    Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group (English)
    Kazutaka Yamaji
    Tomomi Okamoto
    Shohei Yokota
    Arata Watanabe
    Yasuo Horikoshi
    Keiko Asami
    Atsushi Kikuta
    Nobuyuki Hyakuna
    Yutaka Saikawa
    Junichi Ueyama
    Tsutomu Watanabe
    Masahiko Okada
    Takashi Taga
    Kazuhiro Kogawa
    Motoaki Chin
    Asayuki Iwai
    Takeshi Matsushita
    Yasuto Shimomura
    Toshinori Hori
    Masahito Tsurusawa
    Japanese Childhood Cancer Leukemia Study Group
    1 December 2010
    1287-1295

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit